ARG52375
anti-Nuclear pore Complex antibody [39C7]
anti-Nuclear pore Complex antibody [39C7] for ICC/IF,Western blot and Human,Mouse
Controls and Markers antibody; Gene Regulation antibody
Overview
Product Description | Mouse Monoclonal antibody [39C7] recognizes Nuclear pore Complex |
---|---|
Tested Reactivity | Hu, Ms |
Tested Application | ICC/IF, WB |
Host | Mouse |
Clonality | Monoclonal |
Clone | 39C7 |
Isotype | IgG1 |
Target Name | Nuclear pore Complex |
Immunogen | Yeast nuclear preparations. |
Conjugation | Un-conjugated |
Application Instructions
Application Suggestion |
|
||||||
---|---|---|---|---|---|---|---|
Application Note | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Unpurified |
Buffer | Tissue culture supernatant. |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Gene Symbol | Nuclear stain of multiple gene products including Nup62, Nup133 |
---|---|
Background | The nuclear pore complex (NPC) is a very large structure made up of at least 50 different proteins that span the double membrane of the nuclear envelope functioning as a gateway for macromolecular traffic between the cytoplasm and the nucleus (Nakielny and Dreyfuss,1999). Discrete nuclear pore complex proteins or nucleoporins such as NUP98, NUP180 and p62 have been implicated in autoimmune disease and cancer. Patients with primary biliary cirrhosis (PBC) frequently produce autoantibodies against p62 and NUP180 (Wilken et al., 1993; Nesher et al., 2001) while NUP98 translocations have been found in patients with acute myelogenous leukemia (AML) (Jaju et al. 2001). |
Research Area | Controls and Markers antibody; Gene Regulation antibody |